Clinical efficacy of biofeedback therapy on constipation-predominant irritable bowel syndrome
10.3760/cma.j.issn.1674-6554.2014.01.011
- VernacularTitle:生物反馈治疗便秘型肠易激综合征的临床疗效研究
- Author:
Yue YU
;
Nan JIANG
;
Kang HUANG
;
Dan XUE
;
Fengqin CHEN
;
Lili YUAN
;
Qiaomin WANG
- Publication Type:Journal Article
- Keywords:
Constipation-predominant irritable bowel syndrome;
Biofeedback;
Anxiety;
Depression;
Quality of life
- From:
Chinese Journal of Behavioral Medicine and Brain Science
2014;23(1):37-39
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical effects of biofeedback therapy on constipation-predominant irritable bowel syndrome(IBS-C).Methods 30 patients with IBS-C were given to biofeedback therapy,5 times every treatment course.and then their clinical symptoms,mental state and quality of life before the treatment and at the end of treatment with biofeedback therapy were respectively evaluated by symptom scores,self-rating anxiety scale (SAS),self-rating depression scale (SDS),and short form 36 health survey questionnaire (SF-36).Results Post-treatment with biofeedback therapy,there were very significant decrease in total and subscales scores of bowel symptom including abdominal pain/discomfort,abdominal distension,abnormal appearance of defecation,abnormal process of defecation((12.31±2.01) vs (19.16±2.17),(2.95±0.57) vs (5.04±1.04),(2.64±0.92) vs (4.25±1.09),(3.66±1.09) vs (5.10±0.57),(3.06±1.08) vs (4.77±0.95) respectively,P＜0.01).The integration of SAS and SDS were obviously decreased after treatment((39.53±6.39) vs (44.43±7.89),P＜0.05;(40.70±8.38) vs (46.46±8.74),P＜0.05),the SF-36 scores were also improved in five dimensions including rolephysical,social-functioning,vitality,role-emotional and mental health((74.16±21.25) vs (57.0±39.40),(86.21±13.54) vs (75.54±20.96),(75.16±13.42) vs (64.66±20.54),(78.87±28.36) vs (57.76±46.26),(81.60±16.08) vs (71.20±22.04) respectively,P＜0.05).Conclusion Biofeedback therapy can improve the clinical symptoms,alleviate the moods of anxiety and depression,and improve the quality of life in patients with IBS-C.
